Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.99
Delayed Data
As of 4:00pm ET
 +0.54 / +1.52%
Today’s Change
29.83
Today|||52-Week Range
36.21
+10.81%
Year-to-Date
US Market Indexes Gain on Wednesday
5:01pm / GuruFocus News - Paid Partner Content
Catalyst (CPRX) Focused on Two Lead Pipeline Candidates
Sep 18 / Zacks.com - Paid Partner Content
Pfizer takes on J&J with antitrust lawsuit
1:11pm / FT.com - Paid Partner Content
Neos Therapeutics ADHD Drug Adzenys Receives Approval in US
Sep 18 / Zacks.com - Paid Partner Content
Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View
10:53am / Zacks.com - Paid Partner Content
Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle
Sep 16 / TheStreet.com - Paid Partner Content
Stocks Edge Higher With Dow Hitting Record High
Sep 19 / GuruFocus News - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content
The 6 Medications Being Used to Tackle the Opioid Epidemic
Sep 18 / TheStreet.com - Paid Partner Content
Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.45
Today’s open35.93
Day’s range35.81 - 36.21
Volume25,634,250
Average volume (3 months)18,881,880
Market cap$211.1B
Dividend yield3.56%
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.73%
Earnings growth (next 5 years)+5.75%
Revenue growth (last year)+8.13%
P/E ratio26.3
Price/Sales3.79
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.07-0.08%
MRKMerck-0.16-0.24%
SNYSanofi-0.02-0.04%
ABBVAbbVie+1.04+1.20%
Data as of 4:02pm ET, 09/20/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts